End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,139 MXN | -5.44% | 0.00% | +2.27% |
05:10pm | Russian court seizes $462.7 mln euros of UniCredit assets | RE |
May. 16 | Evercore ISI Adjusts Price Target on Linde to $465 From $425, Keeps Outperform Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 30.53 and 27.44 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.27% | 207B | - | ||
+21.82% | 12.89B | B | ||
+66.66% | 9.18B | C+ | ||
-9.04% | 3.56B | D+ | ||
+16.35% | 3.29B | C- | ||
+15.47% | 3.22B | C+ | ||
-14.82% | 2.08B | - | ||
-11.34% | 1.8B | - | ||
+7.09% | 1.72B | - | - | |
-23.20% | 1.21B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LIN Stock
- LIN1 N Stock
- Ratings Linde plc